NCI @ LGCW 2024: A Framework for Monitoring Progress at the Intersection of Women, Power, and Cancer

London Global Cancer Week

November 13, 2024 | 11:00 AM – 12:30 PM

Virtual

Add to Outlook Calendar

Register Now

The Lancet Commission on Women, Power, and Cancer addresses urgent questions at the intersection of social inequality, cancer risk and outcomes, and the status of women in society. The Commission has identified key performance indicators to evaluate the global implementation of the ten key recommendations for impactful and lasting change, as proposed in the September 2023 Commission report. The NCI convenes this London Global Cancer Week session to introduce these indicators and discuss opportunities and challenges of implementation, as well as monitoring and evaluating progress.

Speaker Information

 

Ibtihal Fadhil, M.B.Ch.B., M.Sc., Ph.D., is the Founding Chair of the Eastern Mediterranean Noncommunicable Disease (NCD) Alliance and the MENA Coalition for HPV Elimination. She is also a former Regional Adviser for NCDs at the WHO's Regional Office for the Eastern Mediterranean. A public health physician, Dr. Fadhil holds Master's and Ph.D. degrees in public health and epidemiology from the London School of Hygiene and Tropical Medicine, University of London. Her work focuses on strengthening the NCD-civil society organization (CSO) network and promoting the role of CSOs at national and regional levels. 

Throughout her 36-year career, Dr. Fadhil has held various academic and clinical positions, including serving as an NCD consultant for the Ministries of Health in the United Arab Emirates, Bahrain, Jordan, and Iraq and as an Assistant Professor of Community Health in Iraq, Jordan, and Bahrain. She has authored numerous papers and commentaries on NCDs, public health, and cancer policy and actively participates in advisory groups and committees for international NCD initiatives, such as the Lancet Commission on Women, Power, and Cancer; Lancet Commission on Oncological Surgery; WHO CSO Working Group on NCDs; and as Project Lead for cancer control in the Eastern Mediterranean region. 

 

Elise Garton, M.Sc., joined the U.S. National Cancer Institute (NCI) in 2020 as a Presidential Management Fellow and is now a Health Specialist in the Partnerships and Dissemination Branch at the Center for Global Health. In this role, Ms. Garton works to advance global cancer research and collaboration by providing analyses, evaluations, and tools to support evidence-based program design and dissemination efforts. During her fellowship, she completed a detail at the U.S. Agency for International Development working on digital health and gender equity in global COVID-19 vaccination distribution. Prior to joining NCI, Ms. Garton worked in electronic medical record implementation and sales in the U.S. and Middle East. 

 

 

 

 

Ophira Ginsburg, M.D., M.Sc., is a Medical Oncologist and global women’s health researcher with 20 years of experience in global cancer prevention and control. Prior to joining the NCI Center for Global Health in 2022, she held faculty positions at the University of Toronto and New York University, and was a Medical Officer at the World Health Organization. She has authored over 140 peer-reviewed articles and commentaries, and co-chairs The Lancet Commission on Women, Power, and Cancer. In 2022, Dr. Ginsburg received the Humanitarian Award from the American Society of Clinical Oncology.

 

 

 

 

Nazik Hammad, M.D., M.Sc., M.E.H.P., F.A.C.P., is Professor of medical oncology at Saint Michael Hospital, Department of Medicine, University of Toronto. Her academic work and research interests include medical education and workforce development in low and middle-income countries (LMICs), particularly in Sub-Saharan Africa, and competency based medical education in Canada. Other research and academic interests include value-based cancer care, global and local inequities and disparities in cancer, global health and global oncology, cancer in conflict zones, and women as health care professionals. Together with colleagues in Africa she led the first Choosing Wisely Africa initiative. She is a co-author in the Lancet Oncology commission for Cancer in Sub-Saharan Africa and is a commissioner in the recently published Lancet Commission on Women, Power, and Cancer. She is co-chair of the Black Physicians’ Association of Ontario (BPAO) Network for Advancing Medical Black Learners (N-ABL) and is the University of Toronto Department of Medicine Faculty Lead for Toronto Addis Ababa Academic Collaboration (TAAAC).  

 

 

 

Jennifer Moodley, M.B.Ch.B., M.Med., Ph.D., is a Public Health Physician with experience in health systems research, epidemiology, and public policy development. She has worked as a clinician in rural and urban health care settings and has first-hand experience of the challenges in providing health care in resource-constrained environments. Jennifer has been involved in the developing and implementing diverse public health programs and policies; conducting health systems research to support national and provincial public health objectives; and training under- and post-graduates to meet similar responsibilities.  

As Director of Cancer Research in the Faculty of Health Sciences, University of Cape Town, Dr. Moodley supports the development of integrated multi-disciplinary cancer research programs and the translation of research into clinical and public health benefits. Cervical cancer is the leading cause of cancer death among women in Sub-Saharan Africa and much of Dr. Moodley's work has focused on the prevention and control of cervical cancer. This includes research on programmatic challenges in secondary prevention of cervical cancer; formative and cost-effectiveness research on the implementation of an HPV vaccination program; and epidemiological research on the association between human immunodeficiency virus, human papillomavirus, cervical cancer precursors, and cervical cancer in South Africa. Her research also explores the complex journey from symptom recognition to cancer care and seeks to apply innovative approaches to improve timely diagnosis of cancer. 

 

Rachel Nugent, Ph.D., is an affiliate Associate Professor at the University of Washington, Department of Global Health. Dr. Nugent retired in 2023 as Director of the Center for Global NCDs at RTI International. She has more than 30 years of experience in global development as a researcher, practitioner, and policy advisor to governments. Dr. Nugent led the Lancet Task Force on NCDs and Economics in 2018. She is currently a member of the Lancet Commission on Women, Power, and Cancer, The Lancet Commission on Investing in Health 3.0, Food System Economics Commission, and the Advisory Group of the Center for Health Incentives and Behavioral Economics at the University of Pennsylvania. She also serves on the board of the International Alliance for Diabetes Action.  

Dr. Nugent has served in numerous advisory committee and board roles, including for the WHO, World Bank, Children’s Heartlink, and the Coalition for Access to NCD Medicines and Technology. She formerly served as a member of the U.S. Institute of Medicine Committee on Economic Evaluation, the International Expert Group for the Global Nutrition Report, and the External Advisory Committee of the NCD Alliance. Before RTI, Dr. Nugent worked at the Center for Global Development, the Population Reference Bureau, the Fogarty International Center of NIH, and the Food and Agriculture Organization of the United Nations. Rachel was awarded the inaugural Global Health Luminary Award in 2021 by the Washington Global Health Alliance.  

 

Carolyn Taylor is a global advocate for supportive cancer care. As the Founder and Executive Director of Global Focus on Cancer, she leverages her lived experience and expertise to build partnerships and introduce culturally relevant, evidence-based cancer awareness and supportive care initiatives in low-resource settings. 

Ms. Taylor has contributed as an author to over 20 peer-reviewed articles, including the Lancet Commission on Women, Power, and Cancer. She serves on the Steering Committee of the WHO Symposium on Meaningful Engagement and is a current Commissioner for the new Lancet Global Health Commission on People Centered Care for Universal Health Coverage. She frequently presents her work at global cancer conferences and since 2015, has served as the Co-Founder and Co-Chair of the annual South East Asia Breast Cancer Symposium. Additionally, she is a Steering Committee Member for the Global Initiative to Advance Cancer Navigation for Better Outcomes (GINO) project, Editorial Board Member of The Journal of Cancer Survivorship Research and Care, and Advisory Board Member of the Asia Pacific Oncology Alliance.